Clinical Data Presented at the European Congress on Obesity 2022 Demonstrates Weight Loss With GS200 in Adults With Prediabetes and Type 2 DiabetesBusiness Wire • 05/04/22
Gelesis' Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Health and Weight Loss, in New StudyBusiness Wire • 04/29/22
Gelesis Holdings: Advancing Biomimetic Superabsorbent Hydrogels For GI-Related DiseasesSeeking Alpha • 04/19/22
Gelesis Holdings, Inc. (GLS) CEO Yishai Zohar on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/25/22
Gelesis® Reports Fiscal Year 2021 Results and Fiscal Year 2022 Financial OutlookBusiness Wire • 03/24/22
Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online TrafficBusiness Wire • 03/16/22
Plenity® National Media Campaign Kicking Off Today Challenges Restrictive Dieting NormsBusiness Wire • 01/31/22